DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» HCK
HCK
Pdf
Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia
Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors
Supplementary Table 1. in Vitro Side Effect Profiling Study for LDN/OSU-0212320. Neurotransmitter Related Steroids
Mitogenic Synergy Through Multilevel Convergence of Hepatocyte Growth Factor and Interleukin-4 Signaling Pathways
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
Supplementary Material Table of Contents
Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer
SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
Janus Kinases: Components of Multiple Signaling Pathways
Molecular Cloning of L-JAK, a Janus Family Protein-Tyrosine Kinase Expressed in Natural Killer Cells and Activated Leukocytes MASARU KAWAMURA*, DANIEL W
Tyrosine Kinase Inhibitors in Cancer: Breakthrough and Challenges of Targeted Therapy
Comprehensive Translational Control of Tyrosine Kinase Expression by Upstream Open Reading Frames
Cell Growth, Global Phosphotyrosine Elevation, and C-Met Phosphorylation Through Src Family Kinases in Colorectal Cancer Cells
Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer
Tyrosine Kinase Panel
A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
Top View
Phosphoproteomic Mass Spectrometry Profiling Links Src Family Kinases to Escape from HER2 Tyrosine Kinase Inhibition
Identification of New Kinase Clusters Required for Neurite Outgrowth And
RET Oligonucleotide Microarray for the Detection of RET Mutations in Multiple Endocrine Neoplasia Type 2 Syndromes1
Regulation of PDGFR Signaling
A Novel Inhibitor of C-Met and VEGF Receptor Tyrosine Kinases with a Broad
S41467-020-16911-4.Pdf
High Throughput Kinase Discovery, Inhibitor Screening and Specificity Analysis Using Multi-Array Technology
Class Effects of Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia
FLT3 Signalling Pathways in Acute Myeloid Leukaemia
Anti-Hck [Ptyrpser209/211] Phosphospecific Antibody, Unconjugated Code No
Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment
A Requirement for Y841 in Jak3 Enzymatic Activity and Hematopoietic Cancers George Steven Martinez University of Texas at El Paso,
[email protected]
Additional Member of the Protein-Tyrosine Kinase Family: the Src- and Lck-Related Protooncogene C-Tkl
HCK Maintains the Self-Renewal of Leukaemia Stem Cells Via CDK6 In
A Phosphosite Within the SH2 Domain of Lck Regulates Its Activation by CD45
Identification of the SRC-Family Tyrosine Kinase HCK As A
Novel C-Met Inhibitor Suppresses the Growth of C-Met-Addicted Gastric
SIGNAL TRANSDUCTION by the Neu/Erbb-2 RECEPTOR: a POTENTIAL TARGET for ANTI-TUMOR THERAPY to Achieve Tight Regulation of Mitotic